Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal Protein L23a Pseudogene 18 (RPL23AP18) is one of the many pseudogenes related to the ribosomal protein L23a. Pseudogenes are non-functional copies of genes that do not encode proteins but can still influence gene expression and cellular processes. The specific role of RPL23AP18 is not well-defined, and it is not considered a therapeutic target. Pseudogenes like RPL23AP18 can be involved in regulating nearby genes or producing non-coding RNAs, which may indirectly affect biological functions. However, detailed mechanisms or disease associations of RPL23AP18 are not established.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal Protein L23a Pseudogene 18 (RPL23AP18).